These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38315959)

  • 1. Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease.
    Meldrum OW; Donaldson GC; Narayana JK; Xaverius Ivan F; Jaggi TK; Mac Aogáin M; Finney LJ; Allinson JP; Wedzicha JA; Chotirmall SH
    Am J Respir Crit Care Med; 2024 Aug; 210(3):298-310. PubMed ID: 38315959
    [No Abstract]   [Full Text] [Related]  

  • 2. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease.
    Kirkham S; Kolsum U; Rousseau K; Singh D; Vestbo J; Thornton DJ
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1033-9. PubMed ID: 18776153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway Mucin Concentration as a Marker of Chronic Bronchitis.
    Kesimer M; Ford AA; Ceppe A; Radicioni G; Cao R; Davis CW; Doerschuk CM; Alexis NE; Anderson WH; Henderson AG; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez F; Paine R; Woodruff PG; O'Neal WK; Boucher RC
    N Engl J Med; 2017 Sep; 377(10):911-922. PubMed ID: 28877023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbocisteine inhibits the expression of Muc5b in COPD mouse model.
    Song Y; Wang W; Xie Y; Xiang B; Huang X; Guan W; Zheng J
    Drug Des Devel Ther; 2019; 13():3259-3268. PubMed ID: 31571828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
    Opron K; Begley LA; Erb-Downward JR; Li G; Alexis NE; Barjaktarevic I; Barr RG; Bleecker ER; Boucher R; Bowler RP; Christenson SA; Comellas AP; Criner G; Cooper CB; Couper D; Galban CJ; Han MK; Hastie A; Hatt C; Hoffman EA; Kaner RJ; Kesimer M; Krishnan JA; LaFon DC; Martinez FJ; Ortega VE; Peters SP; Paine R; Putcha N; Woodruff PG; Huffnagle GB; Kozik AJ; Curtis JL; Huang YJ;
    Am J Respir Crit Care Med; 2024 Jul; 210(2):186-200. PubMed ID: 38261629
    [No Abstract]   [Full Text] [Related]  

  • 7. Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease.
    Singanayagam A; Footitt J; Marczynski M; Radicioni G; Cross MT; Finney LJ; Trujillo-Torralbo MB; Calderazzo M; Zhu J; Aniscenko J; Clarke TB; Molyneaux PL; Bartlett NW; Moffatt MF; Cookson WO; Wedzicha J; Evans CM; Boucher RC; Kesimer M; Lieleg O; Mallia P; Johnston SL
    J Clin Invest; 2022 Apr; 132(8):. PubMed ID: 35239513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.
    Livraghi-Butrico A; Grubb BR; Wilkinson KJ; Volmer AS; Burns KA; Evans CM; O'Neal WK; Boucher RC
    Mucosal Immunol; 2017 May; 10(3):829. PubMed ID: 28435155
    [No Abstract]   [Full Text] [Related]  

  • 9. MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma.
    Welsh KG; Rousseau K; Fisher G; Bonser LR; Bradding P; Brightling CE; Thornton DJ; Gaillard EA
    Chest; 2017 Oct; 152(4):771-779. PubMed ID: 28716644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
    Kirkham S; Sheehan JK; Knight D; Richardson PS; Thornton DJ
    Biochem J; 2002 Feb; 361(Pt 3):537-46. PubMed ID: 11802783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
    Papi A; Hughes R; Del Olmo R; Agusti A; Chipps BE; Make B; Tomaszewski E; Peres Da Costa K; Srivastava D; Vestbo J; Janson C; Burgel PR; Price D
    Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients.
    Caramori G; Casolari P; Di Gregorio C; Saetta M; Baraldo S; Boschetto P; Ito K; Fabbri LM; Barnes PJ; Adcock IM; Cavallesco G; Chung KF; Papi A
    Histopathology; 2009 Sep; 55(3):321-31. PubMed ID: 19723147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucus plugging on computed tomography and the sputum microbiome in patients with asthma, chronic obstructive pulmonary disease, and asthma-COPD overlap.
    Tanabe N; Matsumoto H; Morimoto C; Hayashi Y; Sakamoto R; Oguma T; Nagasaki T; Sunadome H; Sato A; Sato S; Ohashi K; Tsukahara T; Hirai T
    Allergol Int; 2024 Oct; 73(4):515-523. PubMed ID: 39013753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
    Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
    [No Abstract]   [Full Text] [Related]  

  • 18. Muc5b is required for airway defence.
    Roy MG; Livraghi-Butrico A; Fletcher AA; McElwee MM; Evans SE; Boerner RM; Alexander SN; Bellinghausen LK; Song AS; Petrova YM; Tuvim MJ; Adachi R; Romo I; Bordt AS; Bowden MG; Sisson JH; Woodruff PG; Thornton DJ; Rousseau K; De la Garza MM; Moghaddam SJ; Karmouty-Quintana H; Blackburn MR; Drouin SM; Davis CW; Terrell KA; Grubb BR; O'Neal WK; Flores SC; Cota-Gomez A; Lozupone CA; Donnelly JM; Watson AM; Hennessy CE; Keith RC; Yang IV; Barthel L; Henson PM; Janssen WJ; Schwartz DA; Boucher RC; Dickey BF; Evans CM
    Nature; 2014 Jan; 505(7483):412-6. PubMed ID: 24317696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease.
    Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
    Acta Pharmacol Sin; 2007 Aug; 28(8):1166-74. PubMed ID: 17640479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease.
    Whittaker HR; Pimenta JM; Jarvis D; Kiddle SJ; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3079-3091. PubMed ID: 33268984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.